Endocannabinoids mediate the glucocorticoid-induced inhibition of excitatory synaptic transmission to dorsal raphe serotonin neurons

Journal of Physiology

Volumn 590, Issue 22, 2012, Pages 5795-5808

  Wang, Jue ^a   Shen, Roh Yu ^a   Haj Dahmane, Samir ^a  

^a RESEARCH INSTITUTE ON ADDICTIONS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; CYCLOOXYGENASE 2; DEXAMETHASONE; ENDOCANNABINOID; G PROTEIN COUPLED RECEPTOR; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUTAMIC ACID; STRESS HORMONE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; ENZYME INHIBITION; GLUTAMATE RELEASE; GLUTAMATERGIC SYNAPTIC TRANSMISSION; MALE; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC NERVE CELL; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

ANIMALS; CORTICOSTERONE; CYCLOOXYGENASE 2 INHIBITORS; DEXAMETHASONE; ENDOCANNABINOIDS; EXCITATORY POSTSYNAPTIC POTENTIALS; GLUCOCORTICOIDS; GLUTAMIC ACID; MALE; RAPHE NUCLEI; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED; SEROTONERGIC NEURONS; SIGNAL TRANSDUCTION;

EID: 84869805161     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2012.238659     Document Type: Article

References (52)

1. Abumaria N, Ribic A, Anacker C, Fuchs E & Flügge G (2008). Stress upregulates TPH1 but not TPH2 mRNA in the rat dorsal raphe nucleus: identification of two TPH2 mRNA splice variants. Cell Mol Neurobiol 28, 331-342.
2. Adell A, Casanovas JM & Artigas F (1997). Comparative study in the rat of the actions of different types of stress on the release of 5-HT in raphe nuclei and forebrain areas. Neuropharmacology 36, 735-741.
3. Arevalo C, De Miguel R & Hernandez-Tristan R (2001). Cannabinoid effects on anxiety-related behaviors and hypothalamic neurotransmitters. Pharmacol Biochem Behav 70, 123-131.
4. Breder CD, Dewitt D & Kraig RP (1995). Characterization of inducible cyclooxygenase in rat brain. J Comp Neurol 355, 296-315.
5. Carrasco GA & Van de Kar LD (2003). Neuroendocrine pharmacology of stress. Eur J Pharmacol 463, 235-272.
6. Chevaleyre V, Heifets BD, Kaeser PS, Sudhof TC & Castillo PE (2007). Endocannabinoid-mediated long-term plasticity requires cAMP/PKA signaling and RIM1α. Neuron 54, 801-812.
7. Dallman MF (2005). Fast glucocorticoid actions on brain: back to the future. Front Neuroendocrinol 26, 103-108.
8. Datson NA, van der Perk J, de Kooet ER & Vreugdenhil E (2001). Identification of corticoid-responsive genes in rat hippocampus using serial analysis of gene expression. Eur J Neurosci 14, 675-689.
9. de Kloet ER, Joëls M & Holsboer F (2005). Stress and the brain: from adaptation to disease. Nature Rev 6, 463-475.
10. De Oliveira Alvares L, Engelke DS, Diehl F, Scheffer-Teixeira R, Haubrich J, de Freitas Cassini L, Molina VA & Quillfeldt JA (2010). Stress response recruits hippocampal endocannabinoid system for the modulation of fear memory. Learn Mem 17, 202-229.
11. Di S, Malcher-Lopes R, Halmos KC & Tasker JG (2003). Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: A fast feedback mechanism. J Neurosci 23, 4850-4857.
12. Englander MT, Dulawa SC, Bhansali P & Schmauss C (2005). How stress and fluoxetine modulate serotonin 2C receptor pre-mRNA editing. J Neurosci 25, 648-651.
13. ffrench-Mullen JM (1995). Cortisol inhibition of calcium in guinea pig hippocampal CA1 neurons via G-protein-coupled activation of protein kinase C. J Neurosci 15, 903-911.
14. Fuller RW & Snoddy HD (1990). Serotonin receptor subtypes involved in the elevation of serum corticosterone concentration in rats by direct- and indirect-acting serotonin agonists. Neuroendocrinology 52, 206-211.
15. Graber R & Losa GA (1995). Changes in the activities of signal transduction and transport membrane enzymes in CEM lymphoblastoid cells by glucocorticoid-induced apoptosis. Anal Cell Pathol 8, 159-175.
16. Grahn RE, Will MJ, Hammack SE, Maswood S, McQueen MB, Watkins LR & Maier SF (1999). Activation of serotonin-immunoreactive cells in the dorsal raphe nucleus in rats exposed to an uncontrollable stressor. Brain Res 826, 35-43.
17. 1 receptor antagonist rimonabant in models of emotional reactivity in rodents. Biol Psychiatry 57, 261-267.
18. 2-like dopamine receptor activation excites rat dorsal raphe 5-HT neurons in vitro. Eur J Neurosci 14, 125-134.
19. Haj-Dahmane S & Shen R-Y (2005). The wake-promoting peptide orexin-B inhibits glutamatergic transmission to dorsal raphe nucleus serotonin neurons through retrograde endocannabinoid signaling. J Neurosci 25, 896-905.
20. 1 receptors. J Pharmacol Exp Ther 331, 186-196.
21. Haj-Dahmane S & Shen R-Y (2010). Regulation of plasticity of glutamate synapses by endocannabinoids and the cyclic-AMP/protein kinase A pathway in midbrain dopamine neurons. J Physiol 588, 2589-2604.
22. 1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with specific CB1 agents. Behav Pharmacol 15, 299-304.
23. Heisler LK, Pronchuk N, Nonogaki K, Zhou L, Raber J, Tung L, Yeo GSH, O'Rahilly S, Colmers WF, Elmquist JK & Tecott LH (2007). Serotonin activates the hypothalamic-pituitary-adrenal axis via serotonin 2C receptor stimulation. J Neurosci 27, 6956-6964.
24. Hill MN, Karatsoreos IN, Hillard CJ & McEwen BS (2010). Rapid elevations in limbic endocannabinoid content by glucocorticoid hormones in vivo. Psychoneuroendocrinology 35, 1333-1338.
25. Hill MN & McEwen BS (2010). Involvement of the endocannabinoid system in the neurobehavioral effects of stress and glucocorticoids. Pro Neuropsychopharmacol Biol Psychiatry 34, 791-797.
26. Hill MN, McLaughlin RJ, Pan B, Fitzgerald ML, Roberts CJ, Lee TTY, Karatsoreos IN, Mackie K, Viau V, Pickel VM, McEwen BS, Liu QS, Gorzalka BB & Hillard CJ (2011). Recruitment of prefrontal cortical endocannabinoid signaling by glucocorticoids contributes to termination of the stress response. J Neurosci 31, 10506-10515.
27. Holmes MC, French KL & Seckl JR (1995). Modulation of serotonin and corticosteroid receptor gene expression in the rat hippocampus with circadian rhythm and stress. Mol Brain Res 28, 186-192.
28. Joels M, Hesen W & de Kloet ER (1991). Mineralocorticoid hormones suppress serotonin-induced hyperpolarization of rat hippocampal CA1 neurons. J Neurosci 11, 2288-2294.
29. Johnson LR, Farb C, Morrison JH, McEwen BS & LeDoux JE (2005). Localization of glucocorticoid receptors at postsynaptic membranes in the lateral amygdala. Neuroscience 136, 289-299.
30. Karst K, Beger S, Erdmann G, Schütz G & Joëls M (2010). Metaplasticity of amygdalar responses to the stress hormone corticosterone. Proc Natl Acad Sci U S A 107, 14449-14454.
31. Karst K, Beger S, Turiault M, Tronche F, Schütz G & Joëls M (2005). Mineralocorticoid receptors are indispensable for nongenomic modulation of hippocampal glutamate transmission by corticosterone. Proc Natl Acad Sci U S A 102, 19204-19207.
32. Kim J & Alger BE (2004). Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. Nat Neurosci 7, 697-680.
33. Kirby LG, Allen AR & Lucki I (1995). Regional differences in the effects of forced swimming on the extracellular levels of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid. Brain Res 682, 189-196.
34. Kozak KR, Rowlinson SW & Marnet LJ (2000). Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2. J Biol Chem 275, 33744-33749.
35. 1A autoreceptor functioning in the rat dorsal raphe nucleus. Neuropharmacology 34, 1201-1210.
36. Lanfumey L, Mongeau R, Cohen-Salmon C & Hamon M (2008). Corticosteroid-serotonin interactions in the neurobiological mechanisms of stress-related disorders. Neurosci Biobehav Rev 32, 1174-1184.
37. Liposits Z, Phelix C & Paull WK (1987). Synaptic interaction of serotonergic axons and corticotrophin releasing factor (CRF) synthesizing neurons in the hypothalamic paraventricular nucleus of the rat. A light and electron microscopic immunocytochemical study. Histochemistry 86, 541-549.
38. McEwen BS (2003). Mood disorders and allostatic load. Biol Psychiatry 54, 200-207.
39. Maier C, Runzler D, Schindelar J, Grabner G, Waldhausl W, Kohler G & Luger A (2005). G-protein coupled glucocorticoid receptors on the pituitary cell membrane. J Cell Sci 118, 3353-3361.
40. Malcher-Lopes R, Di S, Marcheselli VS, Weng FJ, Stuart CT, Bazan NG & Tasker JG (2006). Opposing crosstalk between leptin and glucocorticoids rapidly modulates synaptic excitation via endocannabinoid release. J Neurosci 26, 6643-6650.
41. Marchetti MC, Di Marco B, Cifone G, Migliorati G & Riccardi C (2003). Dexamethasone-induced apoptosis of thymocytes: role of glucocorticoid receptor-associated Src kinase and caspase-8 activation. Blood 101, 585-593.
42. Mendelson SD & McEwen BS (1991). Autoradiographic analysis of the effects of restraint-induced stress on 5-HT1A, 5-HT1C and 5-HT2 receptors in the dorsal hippocampus in male and female rats. Neuroendocrinology 54, 454-461.
43. Olijslagers JE, de Kloet ER, Elgersma Y, van Woerden GM, Joëls M & Karst H (2008). Rapid changes in hippocampal CA1 pyramidal cell function via pre- as well as postsynaptic membrane mineralocorticoid receptors. Eur J Neurosci 27, 2542-2550.
44. Orchinik M, Murray TF, Franklin PH & Moore FL (1992). Guanyl nucleotide modulate binding to steroid receptors in neuronal membranes. Proc Natl Acad Sci U S A 89, 3830-3834.
45. Palkovits M (1987). Organization of the stress response at the anatomical level. Prog Brain Res 72, 47-55.
46. Petrov T, Krukoff TL & Jhamanda JH (1994). Chemically defined collateral projections from the pons to the central nucleus of the amygdala and hypothalamic paraventricular nucleus in the rat. Cell Tissue Res 277, 289-295.
47. Prager EM, Brielmaier J, Bergstrom HC, McGuire J & Johnson LR (2010). Localization of mineralococrticoid receptors at mammalian synapses. PloS One 5, e14344.
48. Sawchenko PT, Swanson LW, Steinbusch HW & Verhofstad AA (1983). The distribution of cells of origin of serotonergic inputs to the paraventricular and supraoptic nuclei of the rat. Brain Res 277, 355-360.
49. Slanina KA & Schweitzer P (2005). Inhibition of cyclooxygenase-2 elicits a CB1-mediated decrease of excitatory transmission in rat CA1 hippocampus. Neuropharmacology 49, 653-659.
50. Vane JR, Bakhle YS & Botting RM (1998). Cyclooxygenases 1 and 2. Ann Rev Pharmacol Toxicol 38, 97-120.
51. Vielhaber K, Riemann D, Feige B, Kuelz A, Kirschbaum C & Voderholzer U (2005). Impact of experimentally induced serotonin deficiency by tryptophan depletion on saliva cortisol concentrations. Pharmacopsychiatry 38, 87-94.
52. Zhang MZ, Harris RC & McKanna JA (1999). Regulation of cyclooxygenase-2 (COX-2) in rat renal cortex by adrenal glucocorticoids and mineralocorticoids. Proc Natl Acad Sci U S A 96, 15280-15285.